Cathy Gwin
Senior Director, Communications
A statement by Jaime M. Yassif, PhD, vice president, NTI Global Biological Policy and Programs.
Executive Order 14292 on “Improving the Safety and Security of Biological Research" suggests some promising actions toward protecting modern bioscience and biotechnology against misuse. However, the order threatens to undermine U.S. capabilities to protect the American public from biological threats by requiring a pause in gain-of-function research.
NTI applauds today’s announcement that the International Negotiating Body of the World Health Organization (WHO) has reached a deal on the language of the Pandemic Accord. Pandemics continue to pose a global threat, and this proposed agreement is proof that the world can unify to reduce the most catastrophic risks.
NTI | bio convened two working groups of international biosecurity experts to discuss policy and institutional considerations, and technical operations for the Joint Assessment Mechanism (JAM) to identify the source of high-consequence biological outbreaks of unknown origin.
Jaime Yassif called on government leaders to take urgent steps to strengthen biosafety and biosecurity policy and practices during a hearing convened by the U.S. House Select Subcommittee on the Coronavirus Pandemic.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates